Latin American Center for Malaria Research and Control

拉丁美洲疟疾研究与控制中心

基本信息

项目摘要

DESCRIPTION (provided by applicant): The overall goal of this proposal is the establishment the "Centro Latino Americano de investigacion en Malaria - CLAIM" as a non-Amazonian malaria research center that would generate knowledge and provide technical and scientific support to governments of the partner countries as well as to organizations and health care institutions to further contribute to malaria elimination programs in the regions. CLAIM would initially bring together field sites from Colombia, Peru, Panama and Guatemala, and has plans to further include sites from Ecuador and Honduras and possibly other endemic countries of the Latin American (LA) and the Caribbean such as Haiti. CLAIM will be composed of multiple public and private research centers from the original partner countries, including centers and organizations depending from or associated to the Ministries of Health (MOH) from all participant countries. CLAIM has also involved consultants/collaborators from the Andean Health Organism and/or the US Centers for Disease Control for this ICEMR program. In addition, to the scientists from the partner countries, CLAIM will have the participation of prominent and experienced scientists from other endemic countries such as Ecuador and Brazil, as well as from United State (USA) and Europe. The ICEMR research activities have been divided into three closely inter-related projects as follows: Project 1 on Epidemiology will determine the ecological and epidemiological features in non-Amazonian regions; Project 2 on malaria transmission will address major gaps in our understanding of the ecology, behavior, vector potential, and control of Anopheles malaria vectors to guide the development and implementation of more effective integrated Vector Management (IVM) strategies, and Project 3 on malaria pathogenesis, that it will determine the clinical outcome of malaria infections and its correlation with the immunological status in communities living under different intensifies of malaria transmission in the study region. CLAIM would involve its epidemiology team to closely work with the National Malaria Control Program (NMCP) of all partner countries, to locate and track the "hot spots" and to assess the changing epidemiological conditions, identifying the malaria patterns and establishing linkages with environmental and anthropogenic factors or other determinants of malaria transmission. The study team will provide technical assistance for helping NMCPs improve surveillance operations, including quality control and assurance of data with respect to diagnostics. This ICEMR proposal includes training activities for selected junior scientists and groups of researchers/technicians. Special projects will be initiated by Year 3 of the program and will profit to redirect the program and/or involve other countries. A Data Management (DM) Core will coordinate all research protocol, DM, data analyses and publications. All CLAIM activities will be coordinated by Core A under responsibility of Caucaseco SRC. CLAIM will combine the multidisciplinary and integrated approach to enhance the research underpinnings for effective malaria elimination and possibly eradication. Data and findings generated by this Center are expected to provide input critical to inform future research design and evaluation of new interventions and control strategies. RELEVANCE: This is a comprehensive project designed to establish an international Center of Excellence for Malaria Research in Latin America (CLAIM) composed of multiple public and private research centers from the endemic countries, the USA and Europe working jointly to find alternatives for malaria control. Results will facilitate malaria elimination in low malaria endemic settings. PROJECT 1: Title: Epidemiology of Malaria Transmission in Low to Moderate Settings of Latin America Project Leader: Herrera, S. PROJECT 1 DESCRIPTION (provided by applicant): The main objective of Project 1 is to evaluate the diversity of the ecology and parasite populations related to the epidemiology and clinical findings in order to establish a scientific framework that supports the development of new intervention strategies for malaria elimination in non-Amazonian areas of LA. This goal will be approached through the following specific aims: 1) Study the epidemiology of seasonal malaria and their relationship with parasite population diversity and 2) Identification of risk factors associated with malaria transmission in non-Amazonian areas of LA countries. We hypothesize that circulating Plasmodium populations and their dynamics modulate the clinical manifestations and immune responses in the affected populations and that vector bionomics, parasite population diversity, host biology and behavior, household conditions, and local environmental conditions, act simultaneously to determine malaria transmission and risk of infection. The studies proposed for aim 1 are directed to determine the real prevalence and incidence of malaria by considering both symptomatic and asymptomatic individuals living in seasonal areas in LA. This investigation includes community based cohort studies (prospective studies), active surveillance using temporal cross-sectional studies, and hospital based passive surveillance studies. The studies will be carried out in 7 endemic areas of Colombia, Peru, Panama and Guatemala, where a total of 21 sentinel sites will be studied. Studies will be carried out in three phases: 1) Our own census of the selected population from sentinel sites where inhabitants will be registered using a demographic questionnaire and houses coordinates using a GPS system; 2) thick smear and PCR for malaria diagnose in selected sentinels sites and random sampling in order to determine asymptomatic gametocytes carriers; 3) clinical follow-up and thick smear of asymptomatic at two sentinel sites (one in Colombia (Tierralta) and one in Peru (Sulluna). For aim 2 we will a) assess the conditions of antimalarial use in communities where malaria is endemic, including adherence, self-medication and prophylaxis; and (b) study the conditions of use of antimalarials in the public and private health institutions including the availability and suitability to care guides. In this ICEMR program, we will establish a network of sentinel sites that will be selected integrating bio-geographic criteria (vector and ecological conditions) and epidemiological information. Sentinel sites will provide baseline information on malaria ecology and epidemiology with the goal of characterizing parasite and vector populations resilient to control interventions. Such network will allow supporting current efforts directed to develop population models to quantify disease dynamics and malaria risk-maps to support MOH elimination activities. RELEVANCE: Identify the relationship between environmental factors, parasite characteristics, household conditions and the malaria prevalence related to the epidemiology and clinical findings.
描述(由申请人提供):本提案的总体目标是建立“中美洲拉丁美洲疟疾调查-索赔”,作为一个非亚马逊地区的疟疾研究中心,该中心将为伙伴国家的政府以及组织和卫生保健机构提供知识和技术支持,以进一步促进该地区的疟疾消除计划。CLAIM最初将汇集来自哥伦比亚、秘鲁、巴拿马和危地马拉的现场站点,并计划进一步包括来自厄瓜多尔和洪都拉斯的站点,可能还包括拉丁美洲(LA)和加勒比地区的其他流行国家,如海地。CLAIM将由来自原始伙伴国家的多个公共和私人研究中心组成,包括依赖于或与所有参与国卫生部(MOH)相关的中心和组织。CLAIM还邀请了来自安第斯健康组织和/或美国疾病控制中心的顾问/合作者参与这个ICEMR项目。此外,除了来自伙伴国家的科学家外,CLAIM还将有来自厄瓜多尔和巴西等其他流行国家以及美国和欧洲的杰出和经验丰富的科学家参与。ICEMR的研究活动分为以下三个密切相关的项目:关于流行病学的项目1将确定非亚马逊地区的生态和流行病学特征;关于疟疾传播的项目2将解决我们对疟媒按蚊的生态、行为、媒介潜力和控制的理解方面的主要差距,以指导制定和实施更有效的综合媒介管理(IVM)战略;研究区疟疾传播强度不同的社区中疟疾感染的临床结局及其与免疫状况的相关性。CLAIM将使其流行病学小组与所有伙伴国的国家疟疾控制规划(NMCP)密切合作,定位和跟踪“热点”,评估不断变化的流行病学状况,确定疟疾模式,并建立与环境和人为因素或疟疾传播的其他决定因素的联系。研究小组将提供技术援助,帮助国家预防和控制项目改进监测工作,包括质量控制和诊断数据保证。这项ICEMR提案包括为选定的初级科学家和研究人员/技术人员小组提供培训活动。特殊项目将在项目的第三年启动,并将有利于重新调整项目和/或涉及其他国家。数据管理(DM)核心将协调所有研究方案、DM、数据分析和出版物。所有索赔活动将在Caucaseco SRC负责下由Core A协调。CLAIM将结合多学科和综合方法,以加强有效消除和可能根除疟疾的研究基础。预计该中心产生的数据和发现将为今后的研究设计和评估新的干预措施和控制战略提供重要的信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Socrates Herrera Valencia其他文献

Socrates Herrera Valencia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Socrates Herrera Valencia', 18)}}的其他基金

DISCOVERY AND PRECLINICAL DEVELOPMENT OF EFFICACIOUS P. vivax PRE-ERYTHROCYTIC STAGE MALARIA VACCINES
有效的红细胞前阶段疟疾疫苗的发现和临床前开发
  • 批准号:
    10513808
  • 财政年份:
    2020
  • 资助金额:
    $ 177.07万
  • 项目类别:
DISCOVERY AND PRECLINICAL DEVELOPMENT OF EFFICACIOUS P. vivax PRE-ERYTHROCYTIC STAGE MALARIA VACCINES
有效的红细胞前阶段疟疾疫苗的发现和临床前开发
  • 批准号:
    10305627
  • 财政年份:
    2020
  • 资助金额:
    $ 177.07万
  • 项目类别:
Discovery and preclinical evaluation of Plasmodium falciparum and P. vivax coiled coil antigens for malaria vaccine development
用于疟疾疫苗开发的恶性疟原虫和间日疟原虫卷曲螺旋抗原的发现和临床前评估
  • 批准号:
    10323004
  • 财政年份:
    2020
  • 资助金额:
    $ 177.07万
  • 项目类别:
Discovery and preclinical evaluation of Plasmodium falciparum and P. vivax coiled coil antigens for malaria vaccine development
用于疟疾疫苗开发的恶性疟原虫和间日疟原虫卷曲螺旋抗原的发现和临床前评估
  • 批准号:
    10079466
  • 财政年份:
    2020
  • 资助金额:
    $ 177.07万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8319231
  • 财政年份:
    2011
  • 资助金额:
    $ 177.07万
  • 项目类别:
Epidemiology of Malaria Transmission in Low to Moderate Settings of Latin America
拉丁美洲中低度地区疟疾传播的流行病学
  • 批准号:
    8319228
  • 财政年份:
    2011
  • 资助金额:
    $ 177.07万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8009913
  • 财政年份:
    2010
  • 资助金额:
    $ 177.07万
  • 项目类别:
Epidemiology of Malaria Transmission in Low to Moderate Settings of Latin America
拉丁美洲中低度地区疟疾传播的流行病学
  • 批准号:
    8009908
  • 财政年份:
    2010
  • 资助金额:
    $ 177.07万
  • 项目类别:
Latin American Center for Malaria Research and Control
拉丁美洲疟疾研究与控制中心
  • 批准号:
    8895238
  • 财政年份:
    2010
  • 资助金额:
    $ 177.07万
  • 项目类别:
Latin American Center for Malaria Research and Control
拉丁美洲疟疾研究与控制中心
  • 批准号:
    7945673
  • 财政年份:
    2010
  • 资助金额:
    $ 177.07万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 177.07万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 177.07万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 177.07万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 177.07万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 177.07万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 177.07万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 177.07万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 177.07万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 177.07万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 177.07万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了